VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $50,784,000 | -7.0% | 2,185,154 | -36.3% | 0.02% | -8.3% |
| Q1 2018 | $54,609,000 | -14.9% | 3,430,231 | +11.1% | 0.02% | -11.1% |
| Q4 2017 | $64,168,000 | +132.4% | 3,087,960 | +60.3% | 0.03% | +107.7% |
| Q3 2017 | $27,607,000 | -32.6% | 1,926,532 | -18.6% | 0.01% | -38.1% |
| Q2 2017 | $40,966,000 | +8.4% | 2,367,940 | -30.9% | 0.02% | 0.0% |
| Q1 2017 | $37,797,000 | +24.8% | 3,426,782 | +64.3% | 0.02% | +23.5% |
| Q4 2016 | $30,285,000 | -55.3% | 2,085,684 | -24.4% | 0.02% | -58.5% |
| Q3 2016 | $67,718,000 | +236.1% | 2,758,339 | +175.7% | 0.04% | +215.4% |
| Q2 2016 | $20,147,000 | -79.9% | 1,000,314 | -73.7% | 0.01% | -80.9% |
| Q1 2016 | $99,994,000 | -89.3% | 3,802,060 | -58.5% | 0.07% | -88.8% |
| Q4 2015 | $931,419,000 | +1206.1% | 9,162,991 | +2191.9% | 0.60% | +1086.3% |
| Q3 2015 | $71,314,000 | -6.9% | 399,791 | +15.9% | 0.05% | 0.0% |
| Q2 2015 | $76,617,000 | +14.6% | 344,888 | +2.4% | 0.05% | +10.9% |
| Q1 2015 | $66,881,000 | -58.7% | 336,724 | -70.2% | 0.05% | -59.3% |
| Q4 2014 | $161,812,000 | – | 1,130,675 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |